Todd Pendleton Sells 11,876 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLBGet Free Report) CMO Todd Pendleton sold 11,876 shares of Dolby Laboratories stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $54.55, for a total transaction of $647,835.80. Following the completion of the sale, the chief marketing officer owned 41,480 shares of the company’s stock, valued at $2,262,734. This trade represents a 22.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Dolby Laboratories Trading Down 0.6%

DLB opened at $55.31 on Friday. The stock’s 50-day moving average price is $59.56 and its 200 day moving average price is $63.07. Dolby Laboratories has a 12-month low of $52.45 and a 12-month high of $77.00. The firm has a market cap of $5.23 billion, a price-to-earnings ratio of 21.86 and a beta of 0.86.

Dolby Laboratories (NYSE:DLBGet Free Report) last posted its earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The firm had revenue of $395.63 million for the quarter, compared to analyst estimates of $385.80 million. During the same quarter in the prior year, the company earned $1.34 EPS. Dolby Laboratories’s revenue was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, research analysts forecast that Dolby Laboratories will post 3.2 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were paid a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 annualized dividend and a yield of 2.6%. Dolby Laboratories’s dividend payout ratio is presently 56.92%.

Hedge Funds Weigh In On Dolby Laboratories

A number of institutional investors and hedge funds have recently modified their holdings of the company. Hantz Financial Services Inc. increased its holdings in shares of Dolby Laboratories by 166.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock valued at $25,000 after acquiring an additional 220 shares during the last quarter. Rothschild Investment LLC increased its holdings in shares of Dolby Laboratories by 4,046.7% in the 3rd quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock valued at $45,000 after acquiring an additional 607 shares during the last quarter. Optiver Holding B.V. increased its holdings in shares of Dolby Laboratories by 7,955.6% in the 3rd quarter. Optiver Holding B.V. now owns 725 shares of the electronics maker’s stock valued at $52,000 after acquiring an additional 716 shares during the last quarter. Fifth Third Bancorp increased its holdings in shares of Dolby Laboratories by 34.7% in the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after acquiring an additional 192 shares during the last quarter. Finally, Aquatic Capital Management LLC purchased a new position in shares of Dolby Laboratories in the 3rd quarter valued at about $56,000. Institutional investors and hedge funds own 58.56% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have commented on DLB shares. Barrington Research restated an “outperform” rating and issued a $90.00 price target on shares of Dolby Laboratories in a research note on Monday, April 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Rosenblatt Securities restated a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, January 30th. Finally, Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $90.75.

Check Out Our Latest Report on DLB

Key Headlines Impacting Dolby Laboratories

Here are the key news stories impacting Dolby Laboratories this week:

  • Positive Sentiment: Zacks Research raised multiple forward earnings estimates for Dolby Laboratories, including FY2026, FY2027, FY2028 and several quarterly periods, signaling improved expectations for future profitability and supporting the stock’s long-term outlook.
  • Positive Sentiment: The company’s most recent quarterly results were already solid, with Dolby beating EPS and revenue estimates and posting 7% year-over-year revenue growth, which still provides fundamental support for the shares.
  • Neutral Sentiment: Analyst opinions remain mixed overall, with a “Moderate Buy” consensus and a target price above the current trading range, but one near-term forecast was cut for Q3 2026, creating a balanced near-term outlook.
  • Negative Sentiment: Dolby CMO Todd Pendleton sold 11,876 shares at an average price of $54.55, reducing his stake by 22.26%. Insider sales often weigh on investor sentiment, even when they are routine or personal in nature. SEC filing

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Further Reading

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.